CompletedNot Applicable

Comparative Microarray Analysis in Primary Cutaneous Malignant Melanoma

Germany21 participantsStarted 2011-12

Plain-language summary

Perturbations in microRNA (miRNA) expression profiles has been reported for cutaneous malignant melanoma (CMM). This study will be an exploratory analysis by miRNA expression profiling using microarrays.

Who can participate

Age range1 Year

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Primary Cutaneous Malignant Melanoma * Cutaneous Malignant Melanoma Metastases * Benign Melanocytic Naevi Exclusion Criteria: \- Other Skin Cancer than Primary Cutaneous Malignant Melanoma

Trial details

NCT IDNCT01482260

SponsorRuhr University of Bochum

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2012-01

View on ClinicalTrials.gov More Cutaneous Malignant Melanoma trials